A detailed history of Strive Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Strive Asset Management, LLC holds 21 shares of LLY stock, worth $21,455. This represents 0.15% of its overall portfolio holdings.

Number of Shares
21
Previous 471 95.54%
Holding current value
$21,455
Previous $367 Million 25.4%
% of portfolio
0.15%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$625.65 - $812.69 $211,469 - $274,689
338 Added 1609.52%
359 $274 Million
Q3 2025

Nov 12, 2025

SELL
$625.65 - $812.69 $281,542 - $365,710
-450 Reduced 95.54%
21 $274 Million
Q2 2025

Aug 14, 2025

SELL
$713.71 - $898.95 $200,552 - $252,604
-281 Reduced 37.37%
471 $367 Million
Q1 2025

May 15, 2025

BUY
$725.72 - $929.72 $111,760 - $143,176
154 Added 25.75%
752 $621 Million
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $434,865 - $557,371
598 New
598 $462 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Strive Asset Management, LLC Portfolio

Follow Strive Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strive Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strive Asset Management, LLC with notifications on news.